CNCR vs. ADPV ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Adaptiv Select ETF (ADPV)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$13.56
Average Daily Volume
3,680
67
ADPV
Adaptiv Select ETF
ADPV Description
To achieve its investment objective of long-term capital appreciation, the fund will invest substantially all of its net assets in a portfolio of publicly-listed equity securities of U.S. large capitalization companies during broad U.S. equity market uptrends. The fund will primarily own common stocks, but may also invest in equity securities of REITS to the extent such REITS are among the 1,000 largest capitalized U.S.-listed stocks. It is non-diversified.Grade (RS Rating)
Last Trade
$37.72
Average Daily Volume
6,580
25
Performance
Period | CNCR | ADPV |
---|---|---|
30 Days | -8.93% | 14.99% |
60 Days | -10.14% | 17.87% |
90 Days | -9.48% | 18.61% |
12 Months | 29.20% | 60.39% |
1 Overlapping Holdings
Symbol | Grade | Weight in CNCR | Weight in ADPV | Overlap | |
---|---|---|---|---|---|
EXEL | B | 1.9% | 1.94% | 1.9% |
CNCR Overweight 66 Positions Relative to ADPV
Symbol | Grade | Weight | |
---|---|---|---|
GLUE | C | 2.03% | |
RVMD | C | 1.84% | |
ACLX | C | 1.73% | |
BMY | B | 1.72% | |
ELVN | D | 1.68% | |
XNCR | B | 1.66% | |
MRSN | D | 1.62% | |
BPMC | C | 1.58% | |
KPTI | C | 1.57% | |
REPL | B | 1.56% | |
GNLX | F | 1.56% | |
MGNX | F | 1.55% | |
HCM | D | 1.54% | |
SWTX | C | 1.47% | |
CRBU | F | 1.47% | |
JANX | C | 1.46% | |
ERAS | C | 1.46% | |
DAWN | F | 1.44% | |
IMCR | D | 1.42% | |
RXRX | F | 1.39% | |
SDGR | C | 1.39% | |
ARVN | D | 1.39% | |
AURA | D | 1.38% | |
LYEL | F | 1.35% | |
SNDX | F | 1.34% | |
MRUS | F | 1.33% | |
KYMR | D | 1.32% | |
RPTX | F | 1.32% | |
GERN | D | 1.31% | |
IOVA | F | 1.3% | |
RCUS | F | 1.29% | |
NRIX | D | 1.29% | |
FHTX | D | 1.26% | |
NUVB | C | 1.26% | |
BNTX | D | 1.25% | |
ZNTL | F | 1.25% | |
MRK | F | 1.24% | |
BCYC | F | 1.24% | |
YMAB | F | 1.24% | |
BMEA | F | 1.22% | |
PGEN | F | 1.2% | |
CGEM | F | 1.2% | |
ALLO | F | 1.18% | |
NUVL | D | 1.18% | |
VOR | D | 1.17% | |
GMAB | F | 1.17% | |
TYRA | F | 1.16% | |
KURA | F | 1.16% | |
ACRV | F | 1.15% | |
AUTL | F | 1.13% | |
STRO | F | 1.12% | |
LEGN | F | 1.1% | |
IDYA | F | 1.07% | |
TSVT | F | 1.06% | |
REGN | F | 1.0% | |
ITOS | F | 0.98% | |
IPHA | F | 0.98% | |
SMMT | D | 0.97% | |
ACET | F | 0.97% | |
IMRX | F | 0.95% | |
IMTX | F | 0.93% | |
RLAY | F | 0.91% | |
IGMS | F | 0.88% | |
RAPT | F | 0.88% | |
FATE | F | 0.87% | |
PRLD | F | 0.55% |
CNCR Underweight 24 Positions Relative to ADPV
Symbol | Grade | Weight | |
---|---|---|---|
PLTR | B | -7.92% | |
APP | B | -6.12% | |
HOOD | B | -5.75% | |
PPC | C | -5.68% | |
HBAN | A | -5.31% | |
T | A | -4.74% | |
VIRT | B | -4.7% | |
AMCR | D | -4.61% | |
KEY | B | -4.53% | |
NU | C | -4.23% | |
KMI | A | -3.92% | |
MDU | D | -3.65% | |
RF | A | -3.54% | |
MTG | C | -3.43% | |
VST | B | -3.39% | |
TOST | B | -3.29% | |
CRBG | B | -3.28% | |
CPNG | D | -3.22% | |
OWL | A | -3.14% | |
HIW | D | -3.07% | |
AM | A | -2.76% | |
VKTX | F | -2.72% | |
GTES | A | -2.29% | |
HAYW | B | -1.84% |
CNCR: Top Represented Industries & Keywords
ADPV: Top Represented Industries & Keywords